Thermo Fisher Scientific Inc (TMO): Today's Featured Health Care Laggard

Thermo Fisher Scientific (TMO) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day down 0.8%. By the end of trading, Thermo Fisher Scientific fell $1.27 (-2.3%) to $54.39 on average volume. Throughout the day, 2.3 million shares of Thermo Fisher Scientific exchanged hands as compared to its average daily volume of 2.2 million shares. The stock ranged in price between $53.77-$55.47 after having opened the day at $55.06 as compared to the previous trading day's close of $55.66. Other company's within the Health Care sector that declined today were: Halozyme Therapeutics (HALO), down 49.8%, Dynacq Healthcare (DYII), down 27.1%, AVEO Pharmaceuticals (AVEO), down 26.7%, and K-V Pharmaceutical Company (KV.B), down 25.4%.

• ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!

Thermo Fisher Scientific, Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacture, analysis, discovery, and diagnostics. Thermo Fisher Scientific has a market cap of $20.45 billion and is part of the health services industry. The company has a P/E ratio of 17.8, below the average health services industry P/E ratio of 19.6 and equal to the S&P 500 P/E ratio of 17.7. Shares are up 23.8% year to date as of the close of trading on Wednesday. Currently there are 12 analysts that rate Thermo Fisher Scientific a buy, no analysts rate it a sell, and two rate it a hold.

TheStreet Ratings rates Thermo Fisher Scientific as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, attractive valuation levels, impressive record of earnings per share growth, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

• You can view the full Thermo Fisher Scientific Ratings Report.

On the positive front, Anika Therapeutics (ANIK), up 28.2%, Staar Surgical (STAA), up 26.3%, Cambrex Corporation (CBM), up 22.1%, and ProPhase Labs (PRPH), up 16.8%, were all gainers within the health care sector with HCA Holdings (HCA) being today's featured health care sector leader.

• Use our health care section to find sector-relevant news.
• Or find some new ideas from our top rated stocks lists.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR (XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care (RXD).

• Find other investment ideas from our top rated ETFs lists.

For more information on Thermo Fisher Scientific Inc click any of the following:

• Thermo Fisher Scientific Inc Stock Price

• Thermo Fisher Scientific Inc Analyst Ratings

• Thermo Fisher Scientific Inc Key Stats & Profile

• Thermo Fisher Scientific Inc Earnings

• Thermo Fisher Scientific Inc Ratio Comparison

• Thermo Fisher Scientific Inc Growth Rates

• Thermo Fisher Scientific Inc Balance Sheet

• Thermo Fisher Scientific Inc Cash Flow

• Thermo Fisher Scientific Inc Income Statement